Cannabidiol: FDA Approved New Drug for the Lennox-Gastaut Syndrome and Dravet Syndrome: Pharmacotherapeutics Review
NeuroPharmac Journal
doi 10.37881/1.413
Full Text
Open PDFAbstract
Available in full text
Date
April 25, 2019
Authors
Publisher
NeuroPharmac Journal